Insmed Incorporated (INSM)
NASDAQ: INSM · Real-Time Price · USD
117.26
+1.16 (1.00%)
Nov 10, 2026, 11:09 AM EST - Market open
Insmed Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,520 | 606.42 | 363.71 | 305.21 | 245.36 | 188.46 | |
Revenue Growth | 239.97% | 66.73% | 19.17% | 24.39% | 30.19% | 14.63% |
Cost of Revenue | 237.07 | 122.94 | 85.74 | 65.57 | 55.13 | 44.15 |
Gross Profit | 1,283 | 483.49 | 277.97 | 239.64 | 190.23 | 144.31 |
Selling, General & Admin | 960.24 | 701.17 | 461.12 | 344.5 | 265.78 | 233.67 |
Research & Development | 944.39 | 771.09 | 598.37 | 571.01 | 397.52 | 272.74 |
Amortization of Goodwill & Intangibles | 11.15 | 6 | 5.05 | 5.05 | 5.05 | 5.05 |
Operating Expenses | 1,916 | 1,478 | 1,065 | 920.56 | 668.36 | 511.47 |
Operating Income | -633.13 | -994.78 | -786.57 | -680.93 | -478.12 | -367.16 |
Interest Expense | -81.36 | -83.8 | -85.15 | -81.37 | -27.97 | -40.47 |
Interest & Investment Income | 49.33 | 60.66 | 53.31 | 42.13 | 11.08 | 0.17 |
Other Non Operating Income (Expenses) | -2.03 | -1.84 | 0.03 | 1.86 | -5.94 | -3.33 |
EBT Excluding Unusual Items | -667.2 | -1,020 | -818.38 | -718.32 | -500.95 | -410.79 |
Merger & Restructuring Charges | - | - | - | - | - | -0.6 |
Other Unusual Items | 69.14 | -251.99 | -91.68 | -28.7 | 20.8 | -25.02 |
Pretax Income | -598.06 | -1,272 | -910.07 | -747.01 | -480.15 | -436.41 |
Income Tax Expense | 7.55 | 5.03 | 3.71 | 2.56 | 1.38 | -1.76 |
Net Income | -605.61 | -1,277 | -913.77 | -749.57 | -481.53 | -434.65 |
Net Income to Common | -605.61 | -1,277 | -913.77 | -749.57 | -481.53 | -434.65 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 216 | 199 | 164 | 140 | 123 | 112 |
Shares Outstanding (Diluted) | 216 | 199 | 164 | 140 | 123 | 112 |
Shares Change | 13.66% | 21.32% | 16.81% | 14.14% | 9.74% | 14.86% |
EPS (Basic) | -2.80 | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
EPS (Diluted) | -2.80 | -6.42 | -5.57 | -5.34 | -3.91 | -3.88 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -627.58 | -967.58 | -705.81 | -549.54 | -410.32 | -370.59 |
Free Cash Flow Per Share | -2.90 | -4.86 | -4.30 | -3.91 | -3.33 | -3.31 |
Gross Margin | 84.40% | 79.73% | 76.43% | 78.52% | 77.53% | 76.57% |
Operating Margin | -41.66% | -164.04% | -216.27% | -223.10% | -194.87% | -194.82% |
Profit Margin | -39.85% | -210.54% | -251.24% | -245.59% | -196.26% | -230.63% |
Free Cash Flow Margin | -41.30% | -159.55% | -194.06% | -180.05% | -167.23% | -196.64% |
EBITDA | -611.03 | -980.46 | -777.7 | -667.64 | -465.83 | -351.9 |
EBITDA Margin | -40.21% | -161.68% | -213.82% | -218.75% | -189.86% | -186.72% |
D&A For EBITDA | 22.09 | 14.31 | 8.88 | 13.29 | 12.29 | 15.26 |
EBIT | -633.13 | -994.78 | -786.57 | -680.93 | -478.12 | -367.16 |
EBIT Margin | -41.66% | -164.04% | -216.27% | -223.10% | -194.87% | -194.82% |